DCF — METHODIST CHARLTON MEDICAL CENTER
Enterprise Value: $-489.9M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-489.9M
Enterprise Value
$-154.8M
PV of Cash Flows
$-335.0M
PV of Terminal Value
$-539.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $302.6M | $-30.6M | -10.0% | $-43.4M | $-39.5M |
| Year 2 | $311.6M | $-28.4M | -9.0% | $-41.6M | $-34.4M |
| Year 3 | $321.0M | $-26.0M | -8.0% | $-39.6M | $-29.8M |
| Year 4 | $330.6M | $-25.2M | -8.0% | $-39.2M | $-26.7M |
| Year 5 | $340.5M | $-25.1M | -7.0% | $-39.5M | $-24.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-489.9M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$293.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.10611048587569413
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5